Novel strategies to test biological hypotheses in early drug development for advanced prostate cancer.
about
Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological ReviewStrategies for modern biomarker and drug development in oncology.Castration-Resistant Prostate Cancer Tissue Acquisition From Bone Metastases for Molecular Analyses.Molecular pathways: targeting resistance in the androgen receptor for therapeutic benefitBiomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review.Identification of novel response and predictive biomarkers to Hsp90 inhibitors through mass spectrometry-based proteomic profiling of patient-derived prostate tumor explants.
P2860
Novel strategies to test biological hypotheses in early drug development for advanced prostate cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Novel strategies to test biolo ...... for advanced prostate cancer.
@en
type
label
Novel strategies to test biolo ...... for advanced prostate cancer.
@en
prefLabel
Novel strategies to test biolo ...... for advanced prostate cancer.
@en
P1433
P1476
Novel strategies to test biolo ...... for advanced prostate cancer.
@en
P2093
Johann S de Bono
Roberta Ferraldeschi
P356
10.1373/CLINCHEM.2012.185157
P407
P577
2012-11-30T00:00:00Z